{
  "id": 8306253,
  "title": "New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients",
  "url": "https://urgent.news/2026/09/18/new-teva-study-identifies-the-attributes-that-healthcare-providers",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-18T20:37:06.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/new-teva-study-identifies-the-attributes-that-healthcare-providers-prioritize-when-selecting-a-treatment-for-tardive-dyskinesia-in-older-patients"
  },
  "original_language": "en",
  "account": null,
  "summary": "New data revealed that healthcare providers prioritize drowsiness risk, duration of available data demonstrating long-term response and drug-drug interaction profile when selecting a treatment for tardive dyskinesia (TD) in patients aged ≥55 years Across all four patient profiles, AUSTEDO® (deutetrabenazine) was most closely related to the attributes most valued by healthcare providers These…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}